Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cullinan Therapeutics Inc shares valued at $50,040 were sold by Michaelson Jennifer on Jan 06 ’25. At $12.51 per share, Michaelson Jennifer sold 4,000 shares. The insider’s holdings dropped to 95,760 shares worth approximately $1.08 million following the completion of this transaction.
Also, JENNIFER MICHAELSON purchased 8,000 shares, netting a total of over 101,440 in proceeds.
Before that, AHMED NADIM had sold 8,400 shares from its account. In a trade valued at $99,708, the President and CEO traded Cullinan Therapeutics Inc shares for $11.87 each. Upon closing the transaction, the insider’s holdings decreased to 8,400 shares, worth approximately $2.96 million.
As published in their initiating research note from UBS on October 24, 2024, Cullinan Therapeutics Inc [CGEM] has been a Buy and the price target has been revised to $30. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in early May. As of April 15, 2024, William Blair has initiated its “an Outperform” rating for CGEM. Earlier on February 15, 2024, Wedbush initiated its rating. Their recommendation was “an Outperform” for CGEM stock.
Analyzing CGEM Stock Performance
During the last five days, there has been a surge of approximately 7.04%. Over the course of the year, Cullinan Therapeutics Inc shares have dropped approximately -7.64%. Shares of the company reached a 52-week high of $12.98 on 01/03/25 and a 52-week low of $9.50 on 01/14/25. A 50-day SMA is recorded $11.95, while a 200-day SMA reached $17.20. Nevertheless, trading volume fell to 0.66 million shares from 0.23 million shares the previous day.
Support And Resistance Levels for Cullinan Therapeutics Inc (CGEM)
According to the 24-hour chart, there is a support level at 10.54, which, if violated, would cause prices to drop to 9.82. In the upper region, resistance lies at 11.93. The next price resistance is at 12.60. RSI (Relative Strength Index) is 50.14 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.10, which suggests the price will decrease in the coming days. Percent R is at 26.78%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
